Direct-to-Consumer Genetic Testing Market: Industry Expert View on Future Growth and Market Trends
The growth of direct-to-consumer genetic testing market is attributed to the driving factors, such as the growing incidence of genetic disorders and increasing awareness about the potential benefits of genetic testing drive the market. However, the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth. Various countries are implementing regulations and guidelines for DTC genetic testing editing in a complex global regulatory environment. The US Food and Drug Administration is increasing its oversight of DTC genetic testing companies to ensure accuracy and consumer safety. For instance, in 2020, the FDA granted a single DTC-GT company clearance for the CYP2C19 gene report to provide gene-based prescribing information for clopidogrel and citalopram, removing the need for confirmatory testing for this gene only. Similarly, there were some recent launches of direct-to-consumer (DTC) genetic tests: Invitae Corporation launched its new geneti...